These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31414990)

  • 1. Willingness to Undergo a Risky Treatment to Improve Cognition Among Persons With Cognitive Impairment Who Received an Amyloid PET Scan.
    Jutkowitz E; Van Houtven CH; Plassman BL; Mor V
    Alzheimer Dis Assoc Disord; 2020; 34(1):1-9. PubMed ID: 31414990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuity of care (COC) and amyloid-β PET scan: the CARE-IDEAS study.
    O'Brien EC; Ford CB; Sorenson C; Jutkowitz E; Shepherd-Banigan M; Van Houtven C
    Alzheimers Res Ther; 2023 Jan; 15(1):6. PubMed ID: 36611213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia.
    Rabinovici GD; Gatsonis C; Apgar C; Chaudhary K; Gareen I; Hanna L; Hendrix J; Hillner BE; Olson C; Lesman-Segev OH; Romanoff J; Siegel BA; Whitmer RA; Carrillo MC
    JAMA; 2019 Apr; 321(13):1286-1294. PubMed ID: 30938796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advance directives among cognitively impaired persons who had an amyloid PET scan and their care partners: a mixed-methods study.
    Bélanger E; Couch E; Carroll MS; DePasquale N; Gadbois EA; Shepherd-Banigan M; Jutkowitz E; Van Houtven CH; Plassman BL; Wetle TT
    BMC Palliat Care; 2022 Nov; 21(1):194. PubMed ID: 36336690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How Accurately Do Patients and Their Care Partners Report Results of Amyloid-β PET Scans for Alzheimer's Disease Assessment?
    James HJ; Van Houtven CH; Lippmann S; Burke JR; Shepherd-Banigan M; Belanger E; Wetle TF; Plassman BL
    J Alzheimers Dis; 2020; 74(2):625-636. PubMed ID: 32065790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "I know that my role is going to change": a mixed-methods study of the relationship between amyloid-β PET scan results and caregiver burden.
    Couch E; Belanger E; Gadbois EA; DePasquale N; Zhang W; Wetle T
    Aging Clin Exp Res; 2023 Feb; 35(2):387-397. PubMed ID: 36484946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactions to Amyloid PET Scan Results and Levels of Anxious and Depressive Symptoms: CARE IDEAS Study.
    Bélanger E; D'Silva J; Carroll MS; Van Houtven CH; Shepherd-Banigan M; Smith VA; Wetle TT
    Gerontologist; 2023 Jan; 63(1):71-81. PubMed ID: 35436334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and Outcomes of Amyloid Positivity Among Persons Without Dementia in a Longitudinal, Population-Based Setting.
    Roberts RO; Aakre JA; Kremers WK; Vassilaki M; Knopman DS; Mielke MM; Alhurani R; Geda YE; Machulda MM; Coloma P; Schauble B; Lowe VJ; Jack CR; Petersen RC
    JAMA Neurol; 2018 Aug; 75(8):970-979. PubMed ID: 29710225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid Positron Emission Tomography and Subsequent Health Care Use Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia.
    Rabinovici GD; Carrillo MC; Apgar C; Gareen IF; Gutman R; Hanna L; Hillner BE; March A; Romanoff J; Siegel BA; Smith K; Song Y; Weber C; Whitmer RA; Gatsonis C
    JAMA Neurol; 2023 Nov; 80(11):1166-1173. PubMed ID: 37812437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Amyloid Positron Emission Tomography With Changes in Diagnosis and Patient Treatment in an Unselected Memory Clinic Cohort: The ABIDE Project.
    de Wilde A; van der Flier WM; Pelkmans W; Bouwman F; Verwer J; Groot C; van Buchem MM; Zwan M; Ossenkoppele R; Yaqub M; Kunneman M; Smets EMA; Barkhof F; Lammertsma AA; Stephens A; van Lier E; Biessels GJ; van Berckel BN; Scheltens P
    JAMA Neurol; 2018 Sep; 75(9):1062-1070. PubMed ID: 29889941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Ambient Air Pollution and Amyloid Positron Emission Tomography Positivity in Older Adults With Cognitive Impairment.
    Iaccarino L; La Joie R; Lesman-Segev OH; Lee E; Hanna L; Allen IE; Hillner BE; Siegel BA; Whitmer RA; Carrillo MC; Gatsonis C; Rabinovici GD
    JAMA Neurol; 2021 Feb; 78(2):197-207. PubMed ID: 33252608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Now at least we have something to call it": Patient and care partner experiences receiving an amyloid PET scan.
    Gadbois EA; Bélanger E; Shield RR; Plassman BL; Van Houtven CH; Wetle TF
    J Am Geriatr Soc; 2022 Oct; 70(10):2938-2947. PubMed ID: 35833618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.
    Jansen WJ; Janssen O; Tijms BM; Vos SJB; Ossenkoppele R; Visser PJ; ; Aarsland D; Alcolea D; Altomare D; von Arnim C; Baiardi S; Baldeiras I; Barthel H; Bateman RJ; Van Berckel B; Binette AP; Blennow K; Boada M; Boecker H; Bottlaender M; den Braber A; Brooks DJ; Van Buchem MA; Camus V; Carill JM; Cerman J; Chen K; Chételat G; Chipi E; Cohen AD; Daniels A; Delarue M; Didic M; Drzezga A; Dubois B; Eckerström M; Ekblad LL; Engelborghs S; Epelbaum S; Fagan AM; Fan Y; Fladby T; Fleisher AS; Van der Flier WM; Förster S; Fortea J; Frederiksen KS; Freund-Levi Y; Frings L; Frisoni GB; Fröhlich L; Gabryelewicz T; Gertz HJ; Gill KD; Gkatzima O; Gómez-Tortosa E; Grimmer T; Guedj E; Habeck CG; Hampel H; Handels R; Hansson O; Hausner L; Hellwig S; Heneka MT; Herukka SK; Hildebrandt H; Hodges J; Hort J; Huang CC; Iriondo AJ; Itoh Y; Ivanoiu A; Jagust WJ; Jessen F; Johannsen P; Johnson KA; Kandimalla R; Kapaki EN; Kern S; Kilander L; Klimkowicz-Mrowiec A; Klunk WE; Koglin N; Kornhuber J; Kramberger MG; Kuo HC; Van Laere K; Landau SM; Landeau B; Lee DY; de Leon M; Leyton CE; Lin KJ; Lleó A; Löwenmark M; Madsen K; Maier W; Marcusson J; Marquié M; Martinez-Lage P; Maserejian N; Mattsson N; de Mendonça A; Meyer PT; Miller BL; Minatani S; Mintun MA; Mok VCT; Molinuevo JL; Morbelli SD; Morris JC; Mroczko B; Na DL; Newberg A; Nobili F; Nordberg A; Olde Rikkert MGM; de Oliveira CR; Olivieri P; Orellana A; Paraskevas G; Parchi P; Pardini M; Parnetti L; Peters O; Poirier J; Popp J; Prabhakar S; Rabinovici GD; Ramakers IH; Rami L; Reiman EM; Rinne JO; Rodrigue KM; Rodríguez-Rodriguez E; Roe CM; Rosa-Neto P; Rosen HJ; Rot U; Rowe CC; Rüther E; Ruiz A; Sabri O; Sakhardande J; Sánchez-Juan P; Sando SB; Santana I; Sarazin M; Scheltens P; Schröder J; Selnes P; Seo SW; Silva D; Skoog I; Snyder PJ; Soininen H; Sollberger M; Sperling RA; Spiru L; Stern Y; Stomrud E; Takeda A; Teichmann M; Teunissen CE; Thompson LI; Tomassen J; Tsolaki M; Vandenberghe R; Verbeek MM; Verhey FRJ; Villemagne V; Villeneuve S; Vogelgsang J; Waldemar G; Wallin A; Wallin ÅK; Wiltfang J; Wolk DA; Yen TC; Zboch M; Zetterberg H
    JAMA Neurol; 2022 Mar; 79(3):228-243. PubMed ID: 35099509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of Knowing: Health-Related Behavior Changes following Amyloid PET Results Disclosure in Mild Cognitive Impairment.
    Wang Y; Ren D; Roberts JS; Tamres LK; Lingler JH
    J Prev Alzheimers Dis; 2024; 11(4):958-965. PubMed ID: 39044506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of amyloid-β CSF/PET discordance and tau load 5 years later.
    Reimand J; Collij L; Scheltens P; Bouwman F; Ossenkoppele R;
    Neurology; 2020 Nov; 95(19):e2648-e2657. PubMed ID: 32913020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia.
    Jansen WJ; Ossenkoppele R; Tijms BM; Fagan AM; Hansson O; Klunk WE; van der Flier WM; Villemagne VL; Frisoni GB; Fleisher AS; Lleó A; Mintun MA; Wallin A; Engelborghs S; Na DL; Chételat G; Molinuevo JL; Landau SM; Mattsson N; Kornhuber J; Sabri O; Rowe CC; Parnetti L; Popp J; Fladby T; Jagust WJ; Aalten P; Lee DY; Vandenberghe R; Resende de Oliveira C; Kapaki E; Froelich L; Ivanoiu A; Gabryelewicz T; Verbeek MM; Sanchez-Juan P; Hildebrandt H; Camus V; Zboch M; Brooks DJ; Drzezga A; Rinne JO; Newberg A; de Mendonça A; Sarazin M; Rabinovici GD; Madsen K; Kramberger MG; Nordberg A; Mok V; Mroczko B; Wolk DA; Meyer PT; Tsolaki M; Scheltens P; Verhey FRJ; Visser PJ; ; Aarsland D; Alcolea D; Alexander M; Almdahl IS; Arnold SE; Baldeiras I; Barthel H; van Berckel BNM; Blennow K; van Buchem MA; Cavedo E; Chen K; Chipi E; Cohen AD; Förster S; Fortea J; Frederiksen KS; Freund-Levi Y; Gkatzima O; Gordon MF; Grimmer T; Hampel H; Hausner L; Hellwig S; Herukka SK; Johannsen P; Klimkowicz-Mrowiec A; Köhler S; Koglin N; van Laere K; de Leon M; Lisetti V; Maier W; Marcusson J; Meulenbroek O; Møllergård HM; Morris JC; Nordlund A; Novak GP; Paraskevas GP; Perera G; Peters O; Ramakers IHGB; Rami L; Rodríguez-Rodríguez E; Roe CM; Rot U; Rüther E; Santana I; Schröder J; Seo SW; Soininen H; Spiru L; Stomrud E; Struyfs H; Teunissen CE; Vos SJB; van Waalwijk van Doorn LJC; Waldemar G; Wallin ÅK; Wiltfang J; Zetterberg H
    JAMA Psychiatry; 2018 Jan; 75(1):84-95. PubMed ID: 29188296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid-β PET Scan Results Disclosure and Care-Partner Emotional Well-Being Over Time.
    Shepherd-Banigan ME; Ford CB; Smith VA; Belanger E; Wetle TT; Plassman BL; Burke JR; DePasquale N; O'Brien EC; Sorenson C; Van Houtven CH
    J Alzheimers Dis; 2022; 90(2):775-782. PubMed ID: 36189596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying an Optimal Cutoff of the Montreal Cognitive Assessment to Predict Amyloid-PET Positivity in a Referral Memory Clinic.
    Nair AK; Ramaswamy S; Kan K; Nair S
    Alzheimer Dis Assoc Disord; 2019; 33(3):194-199. PubMed ID: 31305321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of cognitive status, age, and APOE-4 genetic risk on brain FDDNP positron-emission tomography imaging in persons without dementia.
    Small GW; Siddarth P; Burggren AC; Kepe V; Ercoli LM; Miller KJ; Lavretsky H; Thompson PM; Cole GM; Huang SC; Phelps ME; Bookheimer SY; Barrio JR
    Arch Gen Psychiatry; 2009 Jan; 66(1):81-7. PubMed ID: 19124691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated Amyloid-β PET Scan and Cognitive and Functional Decline in Mild Cognitive Impairment and Dementia of Uncertain Etiology.
    Plassman BL; Ford CB; Smith VA; DePasquale N; Burke JR; Korthauer L; Ott BR; Belanger E; Shepherd-Banigan ME; Couch E; Jutkowitz E; O'Brien EC; Sorenson C; Wetle TT; Van Houtven CH
    J Alzheimers Dis; 2024; 97(3):1161-1171. PubMed ID: 38306055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.